Cancer incidence, survival and mortality: Explaining the concepts

International Journal of Cancer

Volumn 135, Issue 8, 2014, Pages 1774-1782

  Ellis, Libby ^a   Woods, Laura M ^a   Estève, Jacques ^b   Eloranta, Sandra ^c   Coleman, Michel P ^a   Rachet, Bernard ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITÉ LYON 1   (France)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

cancer; incidence; methods; mortality; survival

Indexed keywords

ARTICLE; BREAST CANCER; CANCER CONTROL; CANCER INCIDENCE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SCREENING; CANCER SURVIVAL; HUMAN; LUNG CANCER; POPULATION RISK; PRIORITY JOURNAL; SEX DIFFERENCE; SWEDEN; TREND STUDY; UNITED KINGDOM;

CANCER; INCIDENCE; METHODS; MORTALITY; SURVIVAL;

AGED; BREAST NEOPLASMS; ENGLAND; FEMALE; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; SWEDEN;

EID: 84905723833     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28990     Document Type: Article

References (36)

1. General Register Office. The Registrar General's statistical review of England and Wales for the two years 1950-1951: supplement on general morbidity, cancer and mental health. London: HMSO, 1955, pp 59-123.
2. General Register Office. The Registrar-General's statistical review of England and Wales for the two years 1950-1951: supplement on general morbidity, cancer and mental health. London: HMSO, 1955.
3. Autier P, Boniol M, LaVecchia C, et al. Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database. Br Med J 2010; 341: c3620.
4. Berrino F, De Angelis R, Sant M, et al.; EUROCARE Working Group. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol 2007; 8: 773-83.
5. Coleman MP, Forman D, Bryant H, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 2011; 377: 127-38.
6. Autier P, Boniol M,. Caution needed for country-specific cancer survival. Lancet 2011; 377: 99-101.
7. Woods LM, Coleman MP, Lawrence G, et al. Evidence against the proposition that "UK cancer survival statistics are misleading": simulation study with national cancer registry data. Br Med J 2011; 342: d3399.
8. Coleman MP, Rachet B, Woods L, et al. Rebuttal to editorial saying cancer survival statistics are misleading. Br Med J 2011; 343: d4214.
9. Autier P, Boniol M, Héry C, et al. Cancer survival statistics should be viewed with caution. Lancet Oncol 2007; 8: 1050-2.
10. Sant M, Aareleid T, Artioli ME, et al. Ten-year survival and risk of relapse for testicular cancer: a EUROCARE high resolution study. Eur J Cancer 2007; 43: 585-92.
11. Extramural Committee to Assess Measures of Progress Against Cancer. Measurement of progress against cancer. J Natl Cancer Inst 1990; 82: 825-35.
12. Karim Kos HE, de Vries E, Soerjomataram I, et al. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 2008; 44: 1345-89.
13. Percy CL, Stanek E, Gloeckler Ries LA,. Accuracy of cancer death certificates and its effect on cancer mortality statistics. Am J Publ Health 1981; 71: 242-50.
14. Percy CL, Miller BA, Gloeckler Ries LA,. Effect of changes in cancer classification and the accuracy of cancer death certificates on trends in cancer mortality. Ann N Y Acad Sci 1990; 609: 87-97.
15. Laurenti R, Coleman MP, Aylin P., Accuracy of statements of the cause of death on death certificates and the international comparability of mortality statistics. In:, Coleman MP, Aylin P, eds. Death certification and mortality statistics: an international perspective. London: Office for National Statistics, 2000. pp 1-9.
16. Curado MP, Edwards BK, Shin HR, et al., eds. Cancer incidence in five continents, vol. IX. IARC Scientific Publications No. 160. Lyon: International Agency for Research on Cancer, 2007.
17. Berrino F, Estève J, Coleman MP,. Basic issues in the estimation and comparison of cancer patient survival. In:, Berrino F, Sant M, Verdecchia A, et al., eds. Survival of cancer patients in Europe: the EUROCARE study. IARC Scientific Publications No. 132. Lyon: International Agency for Research on Cancer, 1995. 1-14.
18. Pohar Perme M, Stare J, Estève J,. On estimation in relative survival. Biometrics 2012; 68: 113-20.
19. Estève J, Benhamou E, Raymond L., Statistical methods in cancer research, vol. IV. Descriptive epidemiology. IARC Scientific Publications No. 128. Lyon: International Agency for Research on Cancer, 1994.
20. World Health Organisation. International statistical classification of diseases and related health problems, 10th revision. Geneva: WHO, 1994.
21. Nelson CP, Lambert PC, Squire IB, et al. Flexible parametric models for relative survival, with application in coronary heart disease. Stat Med 2007; 26: 5486-98.
22. Lambert PC, Royston P,. Further development of flexible parametric models for survival analysis. Stata J 2009; 9: 265-90.
23. Cancer Research UK Cancer Survival Group. Life tables for England and Wales by sex, calendar period, region and deprivation. London School of Hygiene and Tropical Medicine. Available at: http://www.lshtm.ac.uk/eph/ncde/ cancersurvival/tools/index.html. Last accessed 1 May 2014.
24. Shah A, Rachet B, Mitry E, et al. Survival from bladder cancer in England and Wales up to 2001. Br J Cancer 2008; 99 (Suppl 1): s86-s89.
25. Hutchison GB, Shapiro S,. Lead time gained by diagnostic screening for breast cancer. J Natl Cancer Inst 1968; 41: 665-81.
26. Lambert PC, Thompson JR, Weston CL, et al. Estimating and modelling the cure fraction in population-based cancer survival analysis. Biostatistics 2007; 8: 576-94.
27. Walters S, Maringe C, Coleman MP, et al. Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004-2007. Thorax 2013; 68: 551-64.
28. Walters S, Maringe C, Butler J, et al. Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study. Br J Cancer 2013; 108: 1195-208.
29. Ito Y, Ohno Y, Rachet B, et al. Cancer survival trends in Osaka, Japan: the influence of age and stage at diagnosis. Jpn J Clin Oncol 2007; 37: 452-8.
30. Vostakolaei FA, Karim-Kos HE, Janssen-Heijnen M, et al. The validity of the mortality to incidence ratio as a proxy for site-specific cancer survival. Eur J Public Health 2010; 21: 573-77.
31. Curtis RE, Freedman DM, Ron E, et al., eds. New malignancies among cancer survivors: SEER cancer registries 1973-2000. NIH Publication No. 05-3302. Bethesda, MD: National Cancer Institute, 2006.
32. Mariotto AB, Rowland JH, Ries LAG, et al. Multiple cancer prevalence: a growing challenge in long-term survivorship. Cancer Epidemiol Biomarkers Prev 2007; 16: 566-71.
33. National Cancer Institute. Surveillance, epidemiology and end results program. Multiple primary and histology coding rules. Bethesda, MD: National Cancer Institute, 2007.
34. International Association of Cancer Registries Working Group Report. International rules for multiple primary cancers (ICD-O third edition). Eur J Cancer Prev 2005; 14: 307-8.
35. Rosso S, De Angelis R, Ciccolallo L, et al.; the EUROCARE Working Group. Multiple tumours in survival estimates. Eur J Cancer 2009; 45: 1080-94.
36. Ellison LF,. Measuring the effect of including multiple cancers in survival analyses using data from the Canadian Cancer Registry. Cancer Epidemiol 2010; 34: 550-5.